Advertisement

Topics

FDA to review Sunovion's airflow obstruction drug for COPD patients

04:11 EDT 3 Jul 2017 | SmartBrief

Sunovion Pharmaceuticals' resubmission of its new-drug application for SUN-101/eFlow, or glycopyrrolate, as a long-term, main -More

Original Article: FDA to review Sunovion's airflow obstruction drug for COPD patients

NEXT ARTICLE

More From BioPortfolio on "FDA to review Sunovion's airflow obstruction drug for COPD patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...